Definition/General
Introduction:
Umbilical cord broadness refers to increased cross-sectional diameter above normal gestational age standards
Pathological broadness includes diameter >3.0 cm or above 95th percentile
Normal cord width ranges from 1.5-2.5 cm at term
Broadness assessment identifies excessive cord development and underlying conditions.
Origin:
Cord broadness develops from excessive Wharton jelly accumulation
Maternal diabetes commonly causes cord enlargement
Fetal hyperinsulinemia promotes excessive growth
Cord edema contributes to broadening
Metabolic disorders affect cord development
Genetic conditions may cause inherent broadness.
Classification:
Classified as normal width (1.5-2.5 cm diameter)
Mild broadness (2.5-3.0 cm diameter)
Moderate broadness (3.0-3.5 cm diameter)
Severe broadness (3.5-4.0 cm diameter)
Extreme broadness (>4.0 cm diameter).
Epidemiology:
Normal width in majority of term cords (80-85%)
Mild broadness occurs in 8-12% of cases
Moderate to severe broadness found in 3-7% of pregnancies
Extreme broadness rare but clinically significant
Strong association with maternal diabetes mellitus.
Clinical Features
Presentation:
Broad cord often indicates maternal diabetes or metabolic disorders
Excessive cord bulk visible at delivery
Associated macrosomia common in fetus
Polyhydramnios may accompany broad cords
Delivery complications possible with extreme broadness.
Symptoms:
Maternal diabetes symptoms often present
Fetal macrosomia detected on ultrasound
Polyhydramnios causing maternal discomfort
Large for gestational age fetus
Delivery difficulties with extreme cord broadness.
Risk Factors:
Maternal diabetes mellitus (gestational or pre-existing)
Maternal obesity and metabolic syndrome
Previous history of macrosomic infants
Family history of diabetes
Advanced maternal age
Polycystic ovary syndrome
Excessive gestational weight gain.
Screening:
Maternal diabetes screening protocols
Cord diameter measurement at delivery
Fetal growth assessment during pregnancy
Polyhydramnios evaluation
Metabolic parameter monitoring.
Master Cord Broadness Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
Normal cord shows appropriate bulk for gestational age
Broad cord appears markedly enlarged in diameter
Increased cross-sectional area throughout length
Abundant Wharton jelly content visible
Gelatinous consistency more pronounced.
Characteristics:
Uniform broadness typically throughout cord length
Excessive bulk with maintained vessel proportions
Increased Wharton jelly content apparent
Soft, gelatinous consistency
Smooth surface contours maintained.
Size Location:
Consistent broadness from fetal to placental insertion
Measurement documentation at multiple sites
Comparison with gestational age standards
Regional consistency assessment
Proportionate vessel distribution within enlarged cord.
Multifocality:
Generalized broadness most common pattern
Uniform diameter increase throughout cord length
Proportional enlargement of all cord components
Associated with systemic metabolic effects
Consistent pattern correlating with maternal condition.
Microscopic Description
Histological Features:
Abundant Wharton jelly in broad cords
Increased mucopolysaccharide content
Expanded tissue architecture
Normal vessel structure within enlarged matrix
Enhanced cellular organization with increased matrix.
Cellular Characteristics:
Increased fibroblast population
Enhanced matrix production capacity
Normal cellular organization within expanded matrix
Proportionate endothelial and smooth muscle cells
Abundant extracellular matrix components.
Architectural Patterns:
Expanded tissue organization with increased bulk
Enhanced matrix compartmentalization
Proportionate vessel positioning within enlarged cord
Increased overall tissue volume
Maintained architectural framework with expansion.
Grading Criteria:
Diameter measurement and percentile assessment
Wharton jelly content (markedly increased)
Matrix-to-vessel proportion evaluation
Cellular density and organization assessment
Clinical correlation with maternal diabetes.
Immunohistochemistry
Positive Markers:
Hyaluronic acid markedly increased in broad cords
Collagen markers show enhanced structural framework
CD31 highlights normal vessel distribution
Smooth muscle actin normal in arteries
Vimentin in abundant fibroblast population.
Negative Markers:
Pathological markers typically negative unless complications present
Cytokeratin negative in cord tissue
Inflammatory markers usually absent
Epithelial markers absent
Degenerative markers typically negative.
Diagnostic Utility:
IHC demonstrates abundant matrix content in broad cords
Shows normal tissue organization with expansion
Confirms enhanced cellular population
Identifies matrix synthesis enhancement
Useful for broadness mechanism research.
Molecular Subtypes:
Matrix abundance markers prominently positive
Growth factor markers may be enhanced
Metabolic activity markers
Insulin signaling markers in diabetic cases
Developmental enhancement markers.
Molecular/Genetic
Genetic Mutations:
Insulin signaling genes affecting cord development
Growth factor pathway genes
Matrix synthesis genes determining bulk
Metabolic regulation genes
Glucose metabolism genes influencing cord growth.
Molecular Markers:
Enhanced growth factors (IGF-1, insulin)
Increased matrix synthesis enzymes
Glucose metabolism markers
Anabolic pathway indicators
Developmental enhancement proteins.
Prognostic Significance:
Mild broadness usually indicates well-controlled maternal diabetes
Moderate broadness suggests suboptimal glucose control
Severe broadness associated with poor diabetic control
Extreme broadness predicts neonatal complications
Broadness degree correlates with metabolic control.
Therapeutic Targets:
Management focuses on maternal diabetes optimization
Glucose control improvement strategies
Fetal surveillance enhancement
Delivery timing optimization
Neonatal hypoglycemia prevention protocols.
Differential Diagnosis
Similar Entities:
Normal diameter variation for gestational age
Cord edema from other causes
Measurement artifact or technique variation
Gestational age miscalculation
Multiple vessel cords causing apparent broadness.
Distinguishing Features:
Diabetic broadness: consistent measurements well above normal range with maternal diabetes
Cord edema: pathological fluid accumulation from other causes
Normal variation: within gestational standards
Measurement error: inconsistent results
Multiple vessels: additional vessel presence.
Diagnostic Challenges:
Correlating broadness with maternal diabetic control
Distinguishing diabetic from non-diabetic broadness
Assessing clinical significance of mild broadness
Identifying underlying metabolic disorders
Evaluating neonatal risk implications.
Rare Variants:
Extreme broadness (>5 cm diameter)
Segmental broadness with normal areas
Non-diabetic broadness from other metabolic disorders
Syndromic broadness with genetic conditions
Acquired broadness from pathological processes.
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
Umbilical cord with broadness assessment and measurements
Diagnosis
Umbilical cord [normal diameter/broadness abnormality]
Broadness Measurements
Diameter: [value] cm, Classification: [mild/moderate/severe/extreme] broadness
Percentile Assessment
Gestational age: [X] weeks, Diameter percentile: [X]% (broadness >95th percentile)
Gross Features
Shows [degree] diameter increase with abundant Wharton jelly and gelatinous consistency
Maternal Diabetes Correlation
Maternal diabetes status: [gestational/pre-existing/none], Glucose control: [well-controlled/suboptimal/poor]
Microscopic Correlation
Wharton jelly: [markedly abundant], Matrix content: [significantly increased]
Fetal Correlation
Fetal size: [appropriate/macrosomic], Birth weight: [X] grams ([X]% percentile)
Clinical Correlation
Clinical significance: [maternal diabetes control indicator, fetal macrosomia risk, neonatal implications]
Final Diagnosis
Umbilical cord broadness [diameter] cm ([severity classification], [X]% percentile, associated with [maternal condition])